BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3313314)

  • 21. [Intravenous immunoglobulins. Basic principles, selection criteria and indications for preventive and therapeutic administration].
    Böger RH; Bode-Böger SM; Frölich JC
    Med Klin (Munich); 1995 Sep; 90(9):520-6. PubMed ID: 7476730
    [No Abstract]   [Full Text] [Related]  

  • 22. Secondary antibody deficiency.
    Duraisingham SS; Buckland MS; Grigoriadou S; Longhurst HJ
    Expert Rev Clin Immunol; 2014 May; 10(5):583-91. PubMed ID: 24684706
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Humoral immunity. B lymphocytes; immunoglobulins (structure, diversity, function); clinical practice investigations; concept of humoral immunity deficiency].
    Cogné M
    Rev Prat; 2001 Jan; 51(2):193-202. PubMed ID: 11252947
    [No Abstract]   [Full Text] [Related]  

  • 24. Intravenous immune globulin therapy for antibody immunodeficiency.
    Savéry F
    Clin Ther; 1984; 7(1):69-72. PubMed ID: 6518465
    [TBL] [Abstract][Full Text] [Related]  

  • 25. History of immunoglobulin replacement.
    Eibl MM
    Immunol Allergy Clin North Am; 2008 Nov; 28(4):737-64, viii. PubMed ID: 18940572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [What is safe in the treatment of the infection-prone child?].
    Schulte-Wissermann H
    Kinderkrankenschwester; 1990 Feb; 9(2):47-50. PubMed ID: 2383491
    [No Abstract]   [Full Text] [Related]  

  • 27. [Prevention of infections in primary and secondary antibody deficiency].
    Mikołuć B; Pietrucha B; Motkowski R; Wolska-Kuśnierz B; Heropolitańska-Pliszka E; Bernatowska E
    Przegl Epidemiol; 2009; 63(1):55-60. PubMed ID: 19522227
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Therapeutic use of human immunoglobulins in immune deficiencies].
    Touraine JL
    Arch Fr Pediatr; 1982; 39 Suppl 1():569-72. PubMed ID: 7159180
    [No Abstract]   [Full Text] [Related]  

  • 29. Immunodeficiency associated with motor neuron disease treated with intravenous immunoglobulin.
    Savery F; Hang LM
    Clin Ther; 1986; 8(6):700-2. PubMed ID: 3791365
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Intravenous immunoglobulin substitution in patients with multiple myeloma, Waldenstrom's syndrome and chronic lymphatic leukemia with secondary antibody deficiency syndrome].
    Schedel I
    Beitr Infusionther Klin Ernahr; 1983; 11():52-8. PubMed ID: 6418137
    [No Abstract]   [Full Text] [Related]  

  • 31. [Summary of symposium on infections in individuals with immunodeficiency].
    Zhonghua Yi Xue Za Zhi; 1991 Dec; 71(12):664-70. PubMed ID: 1687448
    [No Abstract]   [Full Text] [Related]  

  • 32. [Immunocorrective therapy in secondary immunologic deficiency].
    Liashenko IuI
    Voen Med Zh; 1988 Mar; (3):28-30. PubMed ID: 3388785
    [No Abstract]   [Full Text] [Related]  

  • 33. Mechanisms and uses of intravenous immune globulin in primary ond secondary immune deficiency disorders. Naples, Florida, October 13-14, 1988.
    J Allergy Clin Immunol; 1989 Oct; 84(4 Pt 2):565-648. PubMed ID: 2794300
    [No Abstract]   [Full Text] [Related]  

  • 34. Immunodeficiency diseases: functional classification.
    Hitzig WH
    Boll Ist Sieroter Milan; 1974; 53(1):suppl:235-40. PubMed ID: 4136798
    [No Abstract]   [Full Text] [Related]  

  • 35. Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology.
    Orange JS; Hossny EM; Weiler CR; Ballow M; Berger M; Bonilla FA; Buckley R; Chinen J; El-Gamal Y; Mazer BD; Nelson RP; Patel DD; Secord E; Sorensen RU; Wasserman RL; Cunningham-Rundles C;
    J Allergy Clin Immunol; 2006 Apr; 117(4 Suppl):S525-53. PubMed ID: 16580469
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immune deficiency states--evaluation and management.
    Abdou NI
    J Kans Med Soc; 1982 May; 83(5):249-51, 260. PubMed ID: 7097104
    [No Abstract]   [Full Text] [Related]  

  • 37. Companies cooperate in emergency supply program for IGIV.
    Landis NT
    Am J Health Syst Pharm; 1999 Apr; 56(7):599. PubMed ID: 10423201
    [No Abstract]   [Full Text] [Related]  

  • 38. Management of primary antibody deficiency with replacement therapy: summary of guidelines.
    Roifman CM; Berger M; Notarangelo LD
    Immunol Allergy Clin North Am; 2008 Nov; 28(4):875-6, x. PubMed ID: 18940580
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Immunotherapy of chronic bronchitis: importance of humoral antibodies].
    Barandun S; Bauer W
    Schweiz Med Wochenschr; 1984 Jun; 114(25):887-90. PubMed ID: 6431609
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Intravenous immunoglobulins in pediatrics].
    Fontán G
    An Esp Pediatr; 1986 Aug; 25(2):77-9. PubMed ID: 3752750
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.